ArticleJournal of global infectious diseases
Pulmonary-renal Syndrome Caused by an Overlap Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-associated Vasculitis Syndrome in the Setting of Immune Complex-mediated Glomerulonephritis in a Patient with COVID-19 Infection.
Article in Journal of global infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 continues to be a global public health issue. Kidney disease is common, mainly presenting as acute kidney injury. Glomerular diseases have been reported in COVID-19. We are presenting a case of immune complex-mediated glomerulonephritis in a patient with COVID-19 infection and probable superimposed systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap who developed a pulmonary-renal syndrome. The patient responded well with a combination of plasma exchange, rituximab, and glucocorticoid therapy. The treatment was successful with resolution of the diffuse alveolar hemorrhage and prevention of potential end stage kidney disease. We would like to add this case to the literature as another example of the long-ranging potential autoimmune/autoinflammatory complications associated with COVID-19 disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.